Allarity Therapeutics, Inc.

Nasdaq:ALLR

Pharmaceutical Preparations·BOSTON, MA

CEO

Jensen Thomas

CFO

Epshinsky Alexander

Financials

19 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/15/25	→
10-Q	Q1 2025	3/31/25	5/9/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/5/24	→
↓

Earnings Releases (8-K)

6 shown

Filed	Period
5/9/25	Q2 FY2025	→
3/31/25	Q1 FY2025	→
11/14/24	Q4 FY2024	→
5/24/24	Q2 FY2024AMENDMENT NO. 1 TO FORM 8-K	→
5/15/24	Q2 FY2024	→
3/8/24	Q1 FY2024	→

News (8-K)

74 shown

Filed	Type	Description
3/6/26	Agreement	Entry into a Material Definitive Agreement	→
2/19/26	Other	Other Events	→
2/4/26	Other	Other Events	→
1/29/26	Agreement	Entry into a Material Definitive Agreement	→
12/23/25	Other	Unregistered Sales of Equity Securities	→
12/8/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
2/12/26	S-3	REGISTRATION STATEMENT	→
1/29/26	424B5	PROSPECTUS SUPPLEMENT	→
12/3/25	S-3	REGISTRATION STATEMENT	→
9/30/25	424B3	424B3	→
9/25/25	S-3	REGISTRATION STATEMENT	→
5/1/25	ARS	ARS	→
↓

Filing History(365 filings)

TypeDateAccessionPeriodSize

8-K

Mar 6, 2026

0001213900-26-024339CURRENT REPORT

Mar 2, 2026

699.1 KB

8-K

Feb 19, 2026

0001213900-26-018161CURRENT REPORT

Feb 18, 2026

210.4 KB

S-3

Feb 12, 2026

0001213900-26-015583REGISTRATION STATEMENT

—

374.6 KB

8-K

Feb 4, 2026

0001213900-26-011826CURRENT REPORT

Feb 3, 2026

223.7 KB

424B5

Jan 29, 2026

0001213900-26-009158PROSPECTUS SUPPLEMENT

—

399.3 KB

8-K

Jan 29, 2026

0001213900-26-009157CURRENT REPORT

Jan 28, 2026

669.2 KB

Jan 16, 2026

0001213900-26-005146OWNERSHIP DOCUMENT

Jan 7, 2026

4.9 KB

8-K

Dec 23, 2025

0001213900-25-124935CURRENT REPORT

Dec 23, 2025

186.0 KB

8-K

Dec 8, 2025

0001213900-25-118989CURRENT REPORT

Dec 3, 2025

364.0 KB

EFFECT

Dec 5, 2025

9999999995-25-003560

—

1.7 KB

S-3

Dec 3, 2025

0001213900-25-117592REGISTRATION STATEMENT

—

800.1 KB

10-Q

Nov 14, 2025

0001437749-25-035003FORM 10-Q

Sep 30, 2025

4.7 MB

Oct 2, 2025

0001213900-25-095391

Sep 30, 2025

8.4 KB

EFFECT

Sep 30, 2025

9999999995-25-003254

—

1.7 KB

424B3

Sep 30, 2025

0001213900-25-094075PROSPECTUS

—

165.3 KB

CORRESP

Sep 30, 2025

0001213900-25-093435

—

8.2 KB

UPLOAD

Sep 29, 2025

0000000000-25-010628

—

39.1 KB

S-3

Sep 25, 2025

0001213900-25-091740REGISTRATION STATEMENT

—

479.4 KB

8-K

Sep 24, 2025

0001213900-25-090872CURRENT REPORT

Sep 22, 2025

225.9 KB

8-K

Sep 22, 2025

0001213900-25-090197CURRENT REPORT

Sep 22, 2025

522.5 KB

8-K

Sep 22, 2025

0001213900-25-089680CURRENT REPORT

Sep 17, 2025

220.0 KB

8-K

Aug 27, 2025

0001213900-25-080923CURRENT REPORT

Aug 26, 2025

209.3 KB

10-Q

Aug 15, 2025

0001437749-25-027146FORM 10-Q

Jun 30, 2025

4.1 MB

NT 10-Q

Aug 14, 2025

0001213900-25-076643NOTIFICATION OF LATE FILING

Jun 30, 2025

20.1 KB

8-K

Jul 16, 2025

0001213900-25-064456CURRENT REPORT

Jul 15, 2025

221.0 KB

25 filings shown

Filed	Form	Description
4/30/25	DEFA14A	FORM DEFA14A	→
4/30/25	DEF 14A	DEF 14A	→
8/20/24	DEFR14A	DEFR14A	→
7/26/24	DEFA14A	DEFA14A	→
7/1/24	DEF 14A	DEF 14A	→
6/21/24	PRE 14A	PRELIMINARY PROXY STATEMENT	→
↓

Filed	Form	Description
1/16/26	4	OWNERSHIP DOCUMENT	→
10/2/25	4	4	→
7/14/25	3	3	→
1/24/25	4/A	FORM 4/A	→
1/24/25	4/A	FORM 4/A	→
1/24/25	4/A	FORM 4/A	→
↓

Allarity Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(365 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/5/25	EFFECT	EFFECT	→
9/30/25	EFFECT	EFFECT	→
6/24/25	RW	WITHDRAWAL OF REGISTRATION STATEMENT ON FORM S-3	→
6/16/25	DRS	DRS	→
8/29/24	SCHEDULE 13G	SCHEDULE 13G	→
5/8/24	RW	RW	→
↓